EPITOPE SUMMARY | |
---|---|
FLLTRILTI is a linear peptidic epitope (epitope ID ) studied as part of Large envelope protein (UniProt:Q76R62) from Hepatitis B virus (Human hepatitis B virus). This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, B cell assays and MHC ligand assays. |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
HLA-A*02:01 | / |
HLA-A*02:02 | / |
HLA-A*02:03 | / |
HLA-A*02:06 | / |
HLA-A*68:02 | / |
HLA class I | / |
HLA-A*03:01 | / |
HLA-A*11:01 | / |
HLA-A*31:01 | / |
HLA-A*68:01 | / |
B Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
dissociation constant KD | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
IFNg release | / |
qualitative binding | / |
cytotoxicity | / |
TNFa release | / |
IL-2 release | / |
degranulation | / |
IL-17A release | / |
decreased disease after adoptive transfer | / |
T cell- APC binding | / |
dissociation constant KD | / |
granzyme B release | / |
IL-21 release | / |
IL-22 release | / |
IL-8 release | / |
pathogen burden after challenge after adoptive transfer | / |
TNF release | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |